on the establishment of vaccination sites, the transport of vaccines, 
information campaigns and promotion of the vaccination of high-risk 
groups. 
 
   Together with other partnerships, Nestlé has committed CHF 10 
million to equitable vaccination efforts to date. Nestlé recently 
announced a contribution to support COVAX 
https://www.globenewswire.com/Tracker?data=eun3tdekoEeqzrX5sFYBt7GtK0KQSFCeH_C6YmLF0-1wNFlh8mztLowy-TG0HfqLExpRThwH8dM0QA1DxUeRadBe0jNoV12my5WK75KYVFzTp2gOk6oHMNsVHTOyV4m-EvAn1pRsEAFC0ujvnvosoybGLtPzDfteDanXjF7ZcOO2B4NsLm5JPipmv7JT1pJy 
to rapidly scale up the international delivery of vaccines to low-income 
countries. We are also working directly with government authorities in 
some countries to provide donations and support for local vaccination 
programs. 
 
   The support for equitable access to vaccines is just the latest phase in 
Nestlé's response to the COVID-19 crisis. We will continue to 
engage in the fight against the pandemic and its consequences, 
protecting people, maintaining global food supply and giving a helping 
hand in our local communities. 
 
   Read more 
https://www.globenewswire.com/Tracker?data=x8OpUYOKohWbzB628yOz1m4PMDAXwd2UxmdKxDZPgBnaWZ-9_raVyKtimc8YCGwK2B6rZrkOKnevPW1tx-RdCIH4TxrmhieqF2BtLKM7Ric_k4m5SM5pYWwQdq66cudjPB_RkLaHAX0ULphj9uPyHun7JQA5e4Sk9uVwergcIvs= 
 
 
 
 
   Outlook 
 
   Full-year 2021 outlook confirmed: continued increase in organic sales 
growth towards a mid single-digit rate. Underlying trading operating 
profit margin with continued moderate improvement. Underlying earnings 
per share in constant currency and capital efficiency expected to 
increase. 
 
 
 
   Annex 
 
 
 
   Three-month sales overview by operating segment 
 
 
 
 
 
 
                                                       Nestlé 
           Total    Zone    Zone    Zone                 Health       Other 
           Group    AMS    EMENA     AOA    Nespresso    Science    Businesses 
Sales 
 3M-2021 
 (CHF m)   21 089   8 244   5 203    5 094      1 571          930          47 
Sales 
 3M-2020 
 (CHF 
 m)*       20 812   8 347   5 313    4 974      1 359          765          54 
Real 
 internal 
 growth 
 (RIG)       6.4%    4.8%    3.8%     8.8%      16.3%         9.4%     - 11.1% 
Pricing      1.2%    2.4%    0.6%     0.3%       0.8%         0.1%        0.3% 
Organic 
 growth      7.7%    7.2%    4.4%     9.1%      17.1%         9.5%     - 10.8% 
Net M&A    - 1.0%    0.3%  - 3.7%   - 3.4%     - 0.1%        17.3%        0.0% 
Foreign 
 exchange  - 5.3%  - 8.6%  - 2.8%   - 3.4%     - 1.4%       - 5.2%      - 2.3% 
Reported 
 sales 
 growth      1.3%  - 1.2%  - 2.1%     2.3%      15.6%        21.6%     - 13.2% 
 
 
 
 
   Three-month sales overview by product 
 
 
 
 
 
 
                                        Milk               Prepared 
                   Powdered           products  Nutrition  dishes & 
           Total   & liquid            & ice    & Health   cooking 
           Group   beverages  Water    cream     Science     aids    Confec-tionery  PetCare 
Sales 
 3M-2021 
 (CHF m)   21 089      5 771   1 389     2 598      2 995     3 016           1 700    3 620 
Sales 
 3M-2020 
 (CHF m)   20 812      5 440   1 586     2 642      3 058     2 952           1 632    3 502 
Real 
 internal 
 growth 
 (RIG)       6.4%       9.3%  - 8.1%     11.6%     - 1.1%      9.9%            9.1%     7.7% 
Pricing      1.2%       0.6%    2.5%      4.1%       0.7%      0.3%            1.2%     1.0% 
Organic 
 growth      7.7%       9.9%  - 5.6%     15.7%     - 0.5%     10.2%           10.3%     8.7% 
 
 
 
   * 2020 figures restated following the disclosure of Nestlé Health 
Science and Nespresso as standalone segments from 2021 onwards 
(previously combined and presented in Other Businesses). 
 
 
 
 
 
 
 
   Contacts: 
 
 
 
   Media: 
 
   Christoph Meier  Tel.: +41 21 924 2200 
 
   mediarelations@nestle.com 
https://www.globenewswire.com/Tracker?data=W9N35iT0KVEarkIIegpNP-aj73cvkOIkmLcxn1OdAKuo0vDlVHTRi3AKucIqhFYPc3hwQBuIDL7nAQsSLbwIFlg0XzyZrtPDHyK7Y-_P5r2kxeD2kTmwMM7M4UmOlnJh 
 
 
 
 
   Investors: 
 
   Luca Borlini  Tel.: +41 21 924 3509 
 
   ir@nestle.com 
https://www.globenewswire.com/Tracker?data=QbWefACpp2TUxFNcuQd1xVdPwEogYJ5TYvnV6sEY-xH6lwvqB4JzBR0SvvqDVnG0sXfcSrdDR4uQI2gXWBjyzw==

(END) Dow Jones Newswires

April 22, 2021 01:15 ET (05:15 GMT)